ReviewCardiovascular drugs and therapy2026
Temporal Coordination of Angiogenic, Nitric Oxide, and Endothelin Pathways in Vascular Adaptation to Hypoxia and Reoxygenation.
Review in Cardiovascular drugs and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeHypoxia induces dynamic vascular adaptations that evolve over time and are further modified by reoxygenation. Although vascular responses are commonly described as either adaptive or maladaptive, the temporal progression of key endothelial signaling pathways remains incompletely integrated across the literature. This narrative review examines how vascular endothelial growth factor (VEGF-A), soluble fms-like tyrosine kinase-1 (sFlt-1), endothelial nitric oxide synthase (eNOS), nitric oxide (NO), nitric oxide synthase trafficking inducer (NOSTRIN), endothelin-1 (ET-1), and angiopoietin/Tie2 signaling contribute to vascular adaptation and dysfunction during acute, subacute, chronic hypoxia, and reoxygenation.
methodsA narrative review of experimental and clinical literature was performed using PubMed/MEDLINE, Embase, Scopus, and Web of Science. Studies evaluating temporal hypoxia-related vascular responses, endothelial signaling pathways, angiogenesis, vascular remodeling, and reperfusion-related mechanisms were synthesized to develop an integrated mechanistic framework.
resultsAcute hypoxia activates compensatory vascular responses characterized by VEGF induction, endothelial adaptation, and modulation of vasodilatory signaling. During subacute hypoxia, angiogenic and remodeling pathways become increasingly engaged, accompanied by progressive endothelial destabilization. Prolonged hypoxia promotes persistent VEGF signaling but is associated with increased anti-angiogenic influences, impaired NO bioavailability, enhanced ET-1 activity, Ang-2 predominance, endothelial dysfunction, and maladaptive vascular remodeling. Reoxygenation represents a distinct biological state in which oxidative stress, inflammation, and endothelial injury may either impair recovery or facilitate restoration of vascular homeostasis, depending on the balance between reparative and damaging pathways.
conclusionVascular adaptation to hypoxia is fundamentally time-dependent and regulated by interconnected endothelial signaling networks. Integrating temporal changes in VEGF/sFlt-1, eNOS/NO, ET-1, NOSTRIN, and Ang/Tie2 pathways provides a mechanistic framework for understanding the transition from adaptive vascular responses to chronic vascular dysfunction and for identifying potential therapeutic targets.
Indexed as
Identifiers
42432347What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.